Cancer, Advanced Active Not Recruiting Phase 1 / 2 Trials for Daratumumab (DB09331)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03098550A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have SpreadTreatment